~" The transit routes of fluid and particulate matter through brain tissue remain unclear. The object of this study was to examine the movement of macromolecules through brain tissue to further clarify the clearance pathways of edema proteins as they migrate toward the cortex. For this purpose, albumin solution (20 ul rat albumin diluted to 65 mg/ml with mock cerebrospinal fluid (CSF)) was intracerebrally infused into the caudate putamen, and the migration through brain tissue as well as through the ultrastructure of the cortical surfaces was explored using an immunocytochemical technique. The authors observed immunoreactive product on the glial limitans and pial lining as well as in the extracellular space of the cortical neuropil at 24 hours postinfusion, confirming that the protein had reached the cortical surface.
T HE pathways and mechanisms by which edema fluid in the extracellular space clears from the brain are not clearly understood. The three possible mechanisms that have been considered responsible for clearance of fluid and extravasated serum protein from the extracellular space are pressuredriven bulk flow into ventricular cerebrospinal fluid (CSF), 6,36.37 glial and neuronal uptake of the protein compounds,~.20.2J.24.28 and reverse vesicular transport from the extracellular space to the blood flow via transendothelial passage. 45"46 Among these mechanisms, the role of bulk flow in the presence of pressure gradients propelling the edema fluid to the ventricular CSF is generally accepted by many investigators. 6' 27"31 ' 35' 36 Our previous studies of the temporal course of a proteinaceous edema fluid clearance, using electron microscopic immunocytochemistry for albumin in direct infusion edema, indicated that the primary path of resolution is via the CSF, not only in the presence but also in the absence of pressure gradients. However, we questioned the mechanism available for clearance when tissue pressure subsides. Under these conditions, other processes must be operative.
The purpose of this study was to further investigate the resolution process of so-called "vasogenic brain edema," by exploring the clearance of edema proteins from the extracellular space of the white matter in the absence of pressure gradients. More specifically, an attempt was made to confirm the role of the CSF pathway by studying the clearance of macromolecules, albumin, and fluorescein isothiocyanate (FITC)-dextrans, using the infusion edema model. 27'3~ Immu-nocytochemical methods provided the sensitivity necessary to investigate the fate of albumin, while the labeled dextrans could be visualized under ultraviolet illumination to identify more clearly the spatial distribution in the absence of pressure gradients.
Materials and Methods

Direct Infusion Model
Sprague-Dawley and Wistar-Furth rats were used in the present studies. The animals were anesthetized by an intraperitoneal injection of pentobarbital (60 rag/ kg). The head was placed in a stereotactic frame and the scalp was incised to expose the skull over both hemispheres. A 1-mm burr hole was drilled in the area 1 mm anterior to the left coronal suture, 3 mm from midline, and the animals were allowed to recover. At 12 days postdrilling, each animal was reanesthetized and the head was placed in a stereotactic frame. A 1-cc syringe was filled with infusate and connected via polyethylene (PE-10) tubing to a No. 30 needle. The infusion needle was inserted into the brain according to the following stereotactic coordinates: bregma + 1.0 mm, 3 mm lateral, 4 mm deep; 20 ul of solution was infused at a rate of 20 ul/hr using an infusion pump.
In this experiment, rat albumin and molecular weight (MW) 71,200-D and 4400-D FITC-dextran (FITC-dextran 71,200 and 4400) were used as infusates. At 15 minutes after the infusion, the infusion needle was carefully removed. The animals were sacrificed after survival periods of 15 minutes or 24 hours; those in the 24-hour postinfusion group were allowed to recover and returned to the holding facility with unrestricted access to food and water.
lmmunocytochemical Study for Albumin
The immunocytochemical methods employed in this study have been reported in detail previously. 3j Briefly, rat albumin was diluted to 65 mg/ml with mock CSF, and 20 ~1 of albumin solution was infused into adult male Sprague-Dawley rats as described above. After survival periods of 15 minutes (three rats) or 24 hours (three rats) postinfusion, the animals were reanesthetized and transcardially perfused with fixative containing 4% paraforrnaldehyde and 0.2% glutaraldehyde. Following perfusion, 50-urn serial coronal sections were taken from the posterior temporal area 3 mm posterior to the needle site. The sections were processed for the immunocytochemical visualization of rat albumin using methods described previously. 3~
Three animals were employed as nonoperated controis while another six animals served as a sham-treated control group for analyzing the effect of a 60-minute needle insertion without infusion. Tissues from these sham-treated animals were studied after sacrifice at 15 minutes (three rats) or 24 hours (three rats) postneedle removal. All brain specimens serving as controls were processed following the same protocols described above.
Preparation of FITC Dextrans
The FITC-dextran 71,200 was obtained commercially.* According to the manufacturer, the polymer had a small degree of polydispersity (Mw/Mn < 1.25) and the degree of substitution is 0.010 M FITC/M glucose residue. Fluorescence was visualized by illuminating the plate with an oblique beam of ultraviolet (UV) light and photographing it using a No. 022 yellow filtert in front of the camera lens. For the experimental series, FITC-dextran 71,200 was purified with three cycles of 2-diethylaminoethanol-column chromatography followed by three cycles of gel filtration. These steps were repeated for the commercial FITC-dextran 4400 (degree of substitution: 0.006 M FITC/M glucose residue).
FITC-Dextran 71,200 in Brain Tissue
The purified FITC-dextran 71,200 was diluted to 65 mg/ml with mock CSF, sterilized, and infused into adult male Sprague-Dawley rats in the same way as the rat albumin. After survival periods of 15 minutes (five animals) or 24 hours (five animals) postinfusion, the rats were reanesthetized and, following perfusion fixation, the brains were quickly removed and sectioned; coronal brain slices were viewed under UV light and photographed using a No. 022 yellow fdter as before. Similar procedures were applied to six noninfused animals to elucidate the effect of needle-insertion only. In addition, diffusion artifacts of FITC-dextran 71,200 during and after perfusion fixation were evaluated by the following two methods. After 15 minutes (three rats) or 24 hours (three rats) postinfusion, animals were reanesthetized and sacrificed with intracardiac injections of KC1. The brain was quickly removed without perfusion fixation, and en bloc brain and sequential coronal sections 3 mm thick were observed under UV light. In a second group of six animals, the brain was quickly removed without perfusion fixation at 15 minutes (three rats) or 24 hours (three rats) and rapidly frozen in dry ice/acetone. Frozen brains were cut into coronal sections 3 mm thick from the frontal pole to the posterior pole. Care was taken to keep the samples frozen by continuous application of dry ice/acetone while cutting. After lyophilization, the coronal sections were observed and photographed under UV light.
Quantification of FITC-Dextran 71,200 in CSF
In all experimental and control animals, CSF was sampled from the cisterna magna just before sacrifice. Concentrations of FITC-dextran 71,200 in CSF were measured using gel-permeation chromatographic fluorometry to estimate the effiux of HTC-dextran 71,200 from brain into CSF spaces. A 100-ul sample of diluted CSF phosphate-buffered saline (pH 7.4) was injected into a high-performance liquid chromatograph equipped with a gel-permeation column~ (8 x 250 mm, 10-u particle size). The column was eluted with phosphatebuffered saline (0.05 M phosphate, 0.15 M NaCI, pH 7.4) at a flow rate of 1.0 ml/min, and the fluorescence intensity was measured with a fluorescence spectrofiuorometerw (X = 490 rim, ~m = 517 nm) with a chart recorder. Relative fluorescence intensity was calculated from the peak height on the chromatogram. A freshly prepared standard solution of FITC-dextran 71,200 (0.2 ug/ml) was run before the CSF samples, so that the concentration of FITC-dextran 71,200 in CSF samples could be calculated from the peak height on the chromatogram of the standard solution. Finally, the CSF concentration of FITC-dextran 71,200 was calculated according to the dilution rate of each CSF sample.
Comparison of Spatial Distribution Between FITCDextrans 71,200 and 4400
Unlabeled dextran of 70,800 D and lower were purchased and further purified by the same method as used for the HTC-dextrans.[I Both unlabeled dextran 70,800 and FITC-dextran 4400 were prepared with mock CSF to achieve a final concentration of 32.5 mg/ml for each molecular compound. Also, FITC-dextran 71,200 and unlabeled dextran 4000 were mixed with mock CSF to achieve a final concentration of 32.5 mg/ml for each compound. In order to equalize the colloid osmotic pressures of the two solutions precisely, each solution was placed in a dialysis bag and both were dialyzed together in baths of mock CSF containing unlabeled dextran 70,800 (32.5 mg/ml) and unlabeled dextran 4000 (32.5 mg/ml). After overnight dialysis, 20 ul of each solution was infused into two groups of SpragueDawley rats (three animals for each mixture). At 15 minutes postinfusion, animals were sacrificed with intracardiac injections of saturated KCI and the brains were quickly removed and frozen in dry ice/acetone. Lyophilized coronal sections 3 mm thick were observed and photographed under UV light. 
Spatial Distribution of FITC-Dextran 71,200 in Rat Brain
Although dextrans of certain concentrations are known to cause anaphylactoid symptoms following intravenous and intraperitoneal injection in SpragueDawley rats, 2's' 34 we have not found this to be true of intracerebrally injected FITC-dextran 72,000 (20 ~1, 65 mg/ml) (unpublished data). Nevertheless, as a further control, the influence of possible dextran toxicity on FITC-dextran distribution was evaluated by repeating the same studies using male adult Wistar-Furth rats, since this strain is completely resistant to dextran. 14'6' 4L43 At 15 minutes (three animals) or 24 hours (three animals) postinfusion of FITC-dextran 71,200 (20 ul, 65 mg/ml), rat brains were fixed with the freeze-drying method described above, and lyophilized coronal sections were macroscopically observed and photographed under UV light. The fluorescence distributions in Wistar-Furth rats were compared to those in SpragueDawley rats.
Results
Immunocytochemical Studies of Albumin
Untreated and Sham-Treated Controls. Immunocytochemical techniques were first evaluated in untreated animals to detect levels of endogenous albumin and/or nonspecific peroxidase reaction on the brain surface. Ultrastructural analysis showed an occasional faint reaction product on both the basal laminae of the glia limitans and the surfaces of the pial linings. In sham-treated animals, the immunoreactivity on the cortical surface of the needle-insertion site was the same as that in untreated animals at both 15 minutes and 24 hours postrecovery (Fig. 1A) . A reaction product was not observed in the extracellular space of the cortical gray matter in either untreated or sham-treated animals. This helped to confirm that artifact was minimal.
Animal Experiments. In the animals sacrificed at 15 minutes postinfusion, no immunoreactivity was observed in the extracellular space of the superficial cortical layer, while a faint reaction product was noticed on the basal laminae of the glia limitans and the surfaces of pial linings as observed in the control study. There was no difference in immunoreactivity on the cortical surfaces between the infusion and the contralateral sites. At 24 hours postinfusion, a small amount of reaction product was observed in the extracellular space of the superficial cortical layer. Surprisingly, the basal laminae of the glia limitans and the surfaces of the pial linings were strongly stained with immunoreaction product at the infusion site (Fig. IC) . By contrast, the cortical surface of the contralateral hemisphere was not stained, although faint reaction products were observed (Fig.  1B) . It was clear that there was a significant difference in immunoreactivity on the cortical surface between the infusion and the contralateral sites. Thus, the movement of tracer by CSF pathway was fimited primarily to the infused hemisphere. 
FITC-Dextran Study
Spatial Distribution of FITC-Dextran 71,200 at 15 Minutes. Brains prepared with perfusion fixation were evaluated first. In animals sacrificed at 15 minutes postinfusion, some fluorescent spots were observed on the cortical surface of en bloc brain at the infusion site. The common finding, which was observed in four of five animals, was the presence of one or two fluorescent spots, ranging from 0.5 to 1 mm in diameter, on the temporobasal surface, where the fluorescence occasionally spread on the surrounding cortical surface ( Fig. 2A  and B) . In two animals, some spots smaller than 0.5 mm in diameter were observed on the temporal and parietal surfaces, but without evidence of spreading. In one animal, the brain surface was not stained with fluorescence. No fluorescent staining was observed on the surface of the olfactory nerves bilaterally or in the contralateral hemisphere.
On coronal sections of the 15-minute postinfusion animals, fluorescence was distributed over a wide expanse of the white matter and caudate putamen, extending to the ventricular wall of the infusion site ( Fig.  3A and B) . However, the conical gray matter was preserved from fluorescent staining. In all animals, the infused FITC-dextran 71,200 passed through the corpus callosum to the contralateral hemisphere to varying extents. In three animals, a thin line of fluorescence was observed passing from the cortical white matter to the cortical surface of the temporal or temporobasal area where the fluorescent spot was observed. These findings of FITC-dextran distribution were very similar to those of albumin movement through brain tissue identified using immunocytochemical methods as reported earlier. 31 Spatial Distribution of FITC-Dextran 71,200 at 24 Hours. In the animals sacrificed at 24 hours postinfusion, the cortical surface of the infusion hemisphere was homogeneously and extensively stained with fluorescence ( Fig. 2C and D) . The most strongly stained region was the surface of the basal area. In four of five animals, the cortical surface of the infusion hemisphere, except for that of the olfactory nerve and the posterior one-fourth of the hemisphere, was strongly stained with fluorescence. In one animal, the entire conical surface of the infusion hemisphere, except for that of the olfactory nerve, was stained with fluorescence. By contrast, on the contralateral hemisphere, the partial cortical surface adjacent to the interhemispheric fissure close to the needle track was only slightly stained.
In the coronal sections of the rats studied 24 hours postinfusion, fluorescence was seen to spread homogeneously throughout the infusion hemisphere including the entire cortical gray matter region (Fig. 3C) . However, the fluorescence intensity of the conical surface was higher than that of the underlying cortical gray matter. Overall fluorescence intensity within the infused hemisphere was decreased in comparison to that of the 15-minute postinfusion animals (see Fig. 3B ). On the contralateral side, fluorescence was observed to spread to the cortical white matter and cortical gray matter of the superomedial area through the corpus callosum. Interestingly, wherever the cortical surface was stained, the underlying cortical gray matter and conical white matter were also stained, not only at the infusion site but also on the contralateral side, suggesting that the fluorescent staining on the conical surface resulted from FITC-dextran migration directly to the cortical surface through the underlying cortical layers.
Comparison of Fluorescence Distribution in Nonperfused Brains. In the brains without perfusion fixation, fluorescent staining on cortical surfaces was the same as that of perfusion-fixed brains in both the 15-minute and the 24-hour postinfusion animals. Thus, we observed no difference in staining of the coronal sections in all animals with or without perfusion fixation. On the coronal sections of freeze-dried brains (Fig. 4) , the margin of the fluorescent-stained area was slightly clearer than on those of perfusion-fixed brains, suggesting little postmortem diffusion of FITC-dextran 71,200 during and after perfusion fixation. In summary, as far as macroscopic observation could determine, there was no essential difference in the spatial distribution of FITC-dextran 71,200 among specimens treated by perfusion fixation, nonfixation, or freeze-drying. These findings provided assurance that subsequent macroscopic evaluations of perfusion-fixed sections were free from artifact.
In the group of sham-treated animals (needle insertion without infusion), fluorescent staining was not observed on the en bloc brain surface or in the coronal sections.
Concentration of FITC-Dextran 71,200 in CSF.
The volume of CSF samples ranged from 78 to 215 ul. The mean CSF concentration of FITC-dexlran 71,200, measured by gel-permeation chromatography at 24 hours postadministration, was 14.3 + 3.3 ug/ml (+ standard deviation) in the intracerebral-infusion group and 0.93 + 0.39 in the intracisternal-injection group with a statistically significant difference between the two values. No fluorescence was detected in CSF in the intravenous-injection group. Thus, FITC-dextran 71,200 was not observed to cross the blood-brain barrier and enter the extracellular space and CSF. Moreover, the behavior of all infused animals upon recovery and return to the holding facility was normal.
Comparison of Spatial Distribution Between FITC-Dextrans 71,200 and 4400. In the animals
infused with the mixture of unlabeled dextran 70,800 and FITC-dextran 4400, fluorescence was observed to have diverged in the cortical gray matter surrounding the fluorescence-rich white matter by 15 minutes postinfusion at the infusion site (Fig. 4B) . By contrast, in the animals infused with the mixture of FITC-dextran 71,200 and unlabeled dextran 4000, fluorescence was distributed similarly to that in FITC-dextran 71,200-infused animals as described in the previous section (Fig. 4A ). This indicated that movement was dependent upon molecular weight and further that the labeling of these compounds was not a factor in the kinetics.
Toxicity of FITC-Dextran 71,200 in Sprague-
Dawley Rat Brain. At 55 minutes postinfusion of dextran 70,800, extravasation of Evans blue dye was observed exclusively along the needle track, approximately 1 mm in diameter, in all animals. In surrounding areas further from the needle track, no Evans blue staining was observed except for the medium eminence and choroid plexus. At 24 hours postinfusion of dextran, in one of three animals, extravasation of Evans blue dye remained along the needle track, although the area of staining was reduced compared to that in the acute animals. In two of three animals, no extravasation of Evans blue dye was observed. There was no difference in the Evans blue staining between dextran-and mock CSF-infused groups. Microscopically, none of the glial, neuronal, and endothelial cellular elements showed a pathological appearance, neither in the mock CSF-infused group nor in the dextran-infused group at 15 minutes postinfusion nor at 24 hours postinfusion, although the extracellular space of the white matter was widely expanded in the former group.
In Wistar-Furth rats infused with FITC-dextran 71,200, the spatial distribution of fluorescence both on the cortical surfaces of en bloc brain and on the coronal sections was the same as that in Sprague-Dawley rats, not only at 15 minutes postinfusion but also at 24 hours Fluorescence was distributed over a wide expansion of the white matter and caudate putamen, passing through the corpus callosum into the contralateral hemisphere. C: Fluorescence was distributed throughout the infusion hemisphere and in the superior medial areas of the contralateral hemisphere. Note that the cortical gray matter and the cortical surface of the infusion site are involved in the fluorescent staining. postinfusion (Fig. 5) . These controls were necessary to show that a possible toxic factor was not involved in governing movement of FITC-dextran 71,200 to the cortical surface. Our morphological results of no extravasation of Evans blue dye and no parenchymal damage after dextran infusion in Sprague-Dawley rat brain confirm that the possible toxicity of dextrans in Sprague-Dawley rat brain was not evident in the present studies. Further, observations of tracer movement in Wistar-Funh rats, which are highly resistant to dextran, were exactly similar to those in Sprague-Dawley rats.
Discussion
In the present studies, an attempt was made to observe the clearance of macromolecules from the white matter to the cortical surface, revealing the kinetics of macromolecular movement via the extracellular space and perivascular channels.
Pathways of Macromolecular Movement to Cortical Surface
The results of our electron microscopic immunocytochemical studies show that the infused albumin moves toward and sinks into the subarachnoid CSF through the extracellular space of the cortical neuropil and the pial lining from the edematous white matter. The remarkable staining by FITC-dextran 71,200 provides confirmation that the majority of the infused hemisphere is involved in this clearance pathway. Additionally, the ultrastructural finding that the infused albumin was mainly observed on the glia limitans at 24 hours postinfusion suggests that most of the fluorescence seen on the conical surface of the en bloc brain originates from FITC-dextran in the subpial area. The assumption of subpial accumulation of FITC-dextran at 24 hours is consistent with the result that the fluorescence intensity on the brain surface was stronger than that of the superficial cortical area in the coronal sections at 24 hours.
The combination of electron microscopic immunocytochemicai study and macroscopic fluorescence observation provides a more comprehensive view of macromolecular movement. The former identified the ultrastructural localization of macromolecule, while the latter defined the extent of spatial distribution. This facilitated the comparison of brain surfaces on both hemispheres. Our use of FITC-dextran 71,200 as a macromolecular marker for albumin (MW 69,000 D), the major component of edema protein, provided several advantages: it was directly visible on the en bloc brain surface under UV light; fluorescein can be detected in small quantities; and it is inert in the central nervous system (CNS). 5' 38 ' 43 
Methodological Consideralions in Use of Labeled Compounds
From the methodological point of view, reliable conclusions derived from the morphological distribution of labeled tracer require the fulfillment of five major criteria: 1) the tracer and its labeling must be stable; 2) there should be no labeled contaminant; 3) there must be no binding of tracer to tissue; 4) the tracer must not damage tissue; and 5) the tissue must be fixed and the tracer kept in the same position at all steps during the histochemical procedure. Our purification of the commercial FITC-dextran 71,200 and the evidence of its stability in the CNS 43 indicate that the fluorescence observed on the brain surface at 24 hours postinfusion resulted from the migration of FITC-dextran 71,200 itself to the cortical surface without any degradation. Moreover, in the present studies, aldehyde fixation was used mainly for technical convenience. Compared with protein tracers, dextrans are much more difficult to immobilize by aldehyde fixatives; j9'29'43'44 however, many investigators have used aldehyde fixation for the ultrastructural localization of dextrans.17'33'40'43 According to our results in comparison of fluorescence distribution among specimens treated by aldehyde fixation, nonfixation, and freeze-drying, no apparent postmortem diffusion artifact was noticed macroscopically in the specimens undergoing perfusion fixation. The fact that the observed spatial distribution of FITC-dextran 71,200 in coronal section at 15 minutes postinfusion is in accordance with that of the infused albumin in the previous study ~1 further confirms the accuracy of our technique.
With the infusion model, the contralateral hemisphere presents an ideal control for the present studies. The observation that the opposite hemisphere was not stained discounts the possibility that albumin and FITC-dextran 71,200 in CSF affected the cortical surface directly. In the electron microscopic immunocytochemical findings and also in the macroscopic fluo- rescence observation, only faint staining was observed on the cortical surface of the contralateral hemisphere. This phenomenon may be explained by the molecular charge. Since FITC-dextrans are uncharged and albumin is negatively charged, these macromolecules have less tendency to form an electrostatic complex with anionic cell coats. 3'8'23'26 Moreover, it has been reported that FITC-dextrans have no appreciable binding to protein and tissues, unlike dyes such as Evans blue. 39 The lack of binding to cortical surface by infused albumin is also an important issue and is supported by our previous observation that immunoreaetion product was not found on the ventricular surfaces of ependymal cells at 15 minutes postinfusion, despite remarkable immunostaining among the intercellular clefts in the infusion site. 3~ Furthermore, since this electric affinity is known to retard the movement of cationic tracers in the interstitial fluid, 3' 8' 23 ' 26 Our results concerning the distribution of uncharged FITC-dextran 71,200 would also not exaggerate the movement of anionic albumin. In summary, we believe that the five major considerations for the use of labeled compounds were satisfied.
Movement of Compounds and Fluid Through Cortical Tissue
Despite numerous laboratory and clinical studies, the role of the extracellular space channels in normal cortical neuropil on the clearance of edema proteins or extracellular substances has rarely been mentioned. Earlier investigations focused morphological attention on the injured cortex and the adjacent cortical area as potential sites for edema formation. Less attention has been paid to the extracellular space of the normal cortex overlying the edematous white matter as a pathway from the edematous white matter to the cortical surface.lL29 One reason might be the limitations of existing models. In the traditional model systems, such as cold injury, hypertension, and radiation, 4' 5~3' j8' 2~ it would have been very difficult to discriminate between edema tracers spreading from the primary lesion in the formation process and those migrating from the edemarich white matter toward the cortical surface in the resolution process, since the cortex is commonly involved in the generation of edema fluid in the primary lesion. Thus, it would have been difficult to separate the resolution process of brain edema from the formation process. The infusion edema model is unique in that it allows the investigator to minimize the injury to the cortex and to study the resolution process separately from the formation process. The present studies, using the infusion edema model, provide compelling morphological evidence for the extracellular space of the entire cortex surrounding the edematous white matter serving as a vast potential route for the fate of edema proteins. Equally important is the possibility that toxins and other substances that may be harmful to the brain follow similar cortical pathways, especially in view of the edematous factors that have been studied by the Baethmann group.
Evidence of Fluid Movement to the Temporobasal Region
In addition to the extraceUular space channels in the cortical neuropil, the fluorescence observation suggests an alternative cortical pathway. The fluorescent lines and points observed on the coronal sections and the en bloc brain surfaces, respectively, at 15 minutes postinfusion support the existence of preferential pathways for the movement of macromolecules to the cortical surface during infusion. In this respect, we have reported earlier that the perivascular spaces of the temporobasal area at the infusion site were stained with the immunoreaction product for albumin at 15 minutes postalbumin infusion? 1 This finding is in accordance with the location of the fluorescent spots on the temporobasal area of brain surface in the present studies. Taking our previous studies into consideration, 3~ it is most likely that, during infusion, HTC-dextran 71,200 reached the cortical surface through the perivascular spaces of venules and veins as a preferential pathway to the cortical surface.
Kinetics of Macromolecular Movement to the Cortical Surface
The finding that FITC-dextran 4400 distributed much more extensively in the cortical gray matter than FITC-dextran 71,200 at 15 minutes postinfusion suggests that dextrans of different MW spread to the cortical surface at different speeds despite the presence of equal pressure gradients during infusion. In this study, an infusate of FITC-dextran 4400 and that of FITCdextran 71,200 were of equal concentration, apart from the different labeling targets. Accordingly, the physiochemical characteristics of the two infusates in the brain were equal. Thus, it is reasonable to suggest that the movement of substances in the extracellular space of the cortical neuropil occurs by diffusion in the absence of pressure gradients. Our finding of diffusion in the extracellular space of the cortical neuropil is supported by the reports of other authors. ~~ Fenstermacher and Patlak ~ have calculated that the normal intercellular spaces of neuropil present too high a resistance to permit an appreciable bulk flow. Since our electron microscopic immunocytochemical studies indicate that the extracellular space of cortical neuropil through which the infused albumin coursed manifested no overt expansion in general, 3~ bulk flow is conceivably not operative there even during infusion. We speculate that the process of bulk flow is restricted to propulsion of fluid along perivascular channels. Bruce, et al.,6 using cold injury, observed the more rapid clearance of sucrose-~4C than dextran-laC (MW 75,000 D) from the brain parenchyma, and suggested that the reabsorption of sucrose from the extracellular space into capillaries was the responsible mechanism accounting for this difference. Alternatively, this phenomenon can be explained by a diffusion concept.
The present studies demonstrate that the molecular movement in the extracellular space of the cortical neuropil occurs primarily by diffusion in the absence or presence of tissue pressure gradients. We suggest that bulk flow along perivascular spaces in the cortical neuropil appear to be comparable to the speed of movement between axonal fibers in the white matter. This is supported by our observation that the infused macromolecules, assisted by the infusion pressure-driving source, reached the cortical surface by 15 minutes postinfusion.
Concept of Edema Resolution via CSF Pathway
The intracellular uptake and transendothelial passage of protein compounds have been reported by other authers to be responsible for the fate of exlravasated serum proteins. 6"2~ However, our previous study showed compelling evidence of the lack of such active endocytotic reactions to infused albumin in the normal brain. 3j Based on the light microscopic and electron microscopic immunoeytochemical results for the infused albumin, we have emphasized earlier that the CSF pathway is a primary route for the resolution process of brain edema. 31 The present morphological results reinforce the concept that the extracellular space of the entire normal cortex surrounding the edematous white matter is a vast potential route for the clearance of edema proteins. Furthermore, the significant difference of FITC-dextran 71,200 concentrations at 24 hours postadministration between the intracerebral-injecfion group and the intracisternal-injection group revealed that FITC-dextran 71,200 continues to sink into the CSF spaces within 24 hours postinfusion, following the initial pressure-driven bulk-flow efflux through the ependymal linings and the perivascular spaces. These quantitative results support the theory that the CSF pathway remains a potential clearance path even in the absence of pressure gradients after infusion.
The movement of substance in the brain parenchyma is a controversial issue. Cserr and coworkers 9 reported that intracerebrally injected radiolabeled tracers of different MW (69,000-D albumin, 4000-D polyethylene glycol, and 900-D polyethylene glycol) were all cleared from the brain at a similar rate (half-time approximately 13 hours). Studies of potential fragmentation of the albumin were not conducted. 5'25 On the basis of these observations, they proposed that bulk flow along the preferential pathways caused by interstitial fluid flow into the CSF spaces 2848 is the mechanism responsible for clearance of substances into the CSF. 7-9 In contrast, Reulen, et al., 36 observed differences in the movement of tracers using the ventriculocisternal perfusion technique following cold injury. On the basis of their findings, they suggested that diffusion is one of the mechanisms responsible for edema clearance. However, these studies did not measure the contribution of the actual driving pressure created by the cold injury. Further studies are required to confirm which mechanism is predominant in the resolution process of edema proteins when the pressure gradients subside. Potential CSF routes include: diffusion through the extracellular space of the cortical neuropil; bulk flow through the extracellular space into ventricular CSF; and bulk flow through the perivascular spaces into the subarachnoid CSF.
Conclusions
The correlation between the immunocytochemical and FITC-dextran 71,200 and 4400 studies reinforces the observation that the two infused macromolecules migrate toward and sink into the subarachnoid CSF via the extracellular space of the cortical neuropil. This occurs in the absence of pressure gradients by 24 hours postinfusion. The different spatial distributions between FITC-dextran 71,200 and 4400 at 15 minutes postinfusion strongly suggest that movement of the two FITCdextrans through the extracellular space of the cortical neuropil occurs by diffusion, despite the presence of the pressure gradients between the edematous loci and the subarachnoid CSF. We conclude that the extracellular space of the normal cortical neuropil surrounding the edematous white matter is a vast potential route for edema proteins and other macromolecules throughout the resolution process of vasogenic brain edema, supporting the theory that the CSF pathway is a primary route responsible for the fate of extracellular edema fluid even in the absence of pressure gradients.
